Long-Term Follow-Up of Mitomycin C Nephropathy

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Two cases of mitomycin C nephropathy, which occurred after postoperative chemotherapy for advanced gastric cancer, were followed up for 6 (case 1) and 10 years (case 2). Hemolytic uremic syndrome developed 68 days (case 1) and 160 days (case 2) after the last administration of MMC with a total dose of 60 mg (case 1) and 40 mg (case 2). Serum creatinine levels were normalized in case 1 and they remained at about 2 mg/dl in case 2. Hyporeninemic hypoaldosteronism was transiently seen in case 2. These data suggest that recovery from the acute phase of hemolytic uremic syndrome leads to a good long-term prognosis in MMC nephropathy. © 1994, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Motoo, Y., Sawabu, N., Takemori, Y., Ohta, H., Okai, T., Ikeda, K., & Yokoyama, H. (1994). Long-Term Follow-Up of Mitomycin C Nephropathy. Internal Medicine, 33(3), 180–184. https://doi.org/10.2169/internalmedicine.33.180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free